StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.29−0.26 (-10.20%)

Close on Nov 20, 2026Market cap $20.65MP/E –Yield –

Nasus Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $1.24B.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.24B–

More Nasus Pharma figures

See a number that looks wrong?